Abstract
Disclosed herein are compositions that are useful for targeting a signaling pathway modulator to a muscle cell. In some instances, such compositions may be useful in treating a muscle disorder, such as muscular dystrophy.
Full Text
What is claimed is:
Disclosed herein are compositions that are useful for targeting a signaling pathway modulator to a muscle cell. In some instances, such compositions may be useful in treating a muscle disorder, such as muscular dystrophy.
Timeline
Filed
05/19/2026Published
09/10/2026Granted
Not AvailableIPC Codes(4)
A61K 47/68:the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61P 21/00:Drugs for disorders of the muscular or neuromuscular system
C07K 14/65:Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2